Related Experiment Video
Updated: Jun 14, 2025

05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
9.6K
[Verification of Pharmaceutical Education System Reform].
1School of Pharmaceutical Sciences, Wakayama Medical University.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|September 1, 2024
Summary
Pharmaceutical education in Japan now requires six years to complete, aligning with a 2006 supplementary resolution. This study confirms that current on-site pharmaceutical education practices meet the resolution
Area of Science:
- Pharmaceutical Education
- Higher Education Policy
Background:
- The Japanese pharmaceutical education system was reformed in 2006, extending the program length to six years.
- This change was mandated by a Diet resolution, accompanied by a supplementary resolution.
- The supplementary resolution aimed to guide the implementation of the extended pharmaceutical education period.
Purpose of the Study:
- To evaluate the compliance of current on-site pharmaceutical education with the 2006 supplementary resolution.
- To assess the alignment of practical pharmaceutical training with policy guidelines.
Main Methods:
- Analysis of the 2006 Diet resolutions concerning pharmaceutical education.
- Review of current on-site pharmaceutical education curricula and practices.
- Comparative assessment of educational content against supplementary resolution stipulations.
Main Results:
- Current pharmaceutical education programs generally adhere to the guidelines set forth in the supplementary resolution.
- On-site training components appear to be consistent with the policy's intent.
- No significant discrepancies were found between educational practices and the supplementary resolution.
Conclusions:
- The current structure of on-site pharmaceutical education aligns well with the objectives of the 2006 supplementary resolution.
- The implementation of the six-year program has successfully incorporated the policy's requirements.
- Pharmaceutical education continues to meet the standards established by the supplementary resolution.
Related Concept Videos
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Pharmacovigilance
789
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
789
Drug Control Governance: Regulatory Bodies and Their Impact
146
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
146
Drug Administration and Therapy Phases: Overview
418
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
418
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Biopharmaceutics and Pharmacokinetics: Overview
1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K

